English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45346/58522 (77%)
造訪人次 : 2504361      線上人數 : 284
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/63107


    題名: 莪朮之生物活性與植化素關係研究
    Study on the relationship between bioactivities and phytochemicals of Curcumae Rhizoma
    作者: 楊宗憲
    YANG, TSUNG-HSIEN
    貢獻者: 生藥學研究所碩士班
    王靜瓊
    關鍵詞: 莪朮;蓬莪朮;廣西莪朮;抗腫瘤;抗氧化;抗發炎;抗凝血;活性指標
    Curcumae Rhizoma;Curcuma phaeocaulis;Curcuma kwangsiensis;anti-tumor;anti-oxidation;anti-inflammation;anti-coagulation;bioactive phytochemicals
    日期: 2023-07-13
    上傳時間: 2023-12-07 09:40:48 (UTC+8)
    摘要: 傳統醫學記載莪朮可廣泛用於治療癥瘕痞塊、痛經經閉、跌打損傷、飲食積滯等多種症狀,本研究利用蓬莪朮和廣西莪朮兩種基原,探討其功效與植化素之關係。本研究利用不同溶劑進行萃取,獲得4種不同莪朮萃取物,透過生物活性試驗結果顯示n-hexane萃取物對於Hep G2 人源肝癌細胞及MG-63 人源骨肉瘤?胞之抑制癌細胞生長作用最強,其IC50分別為蓬莪朮344.46 μg/mL、282.41 μg/mL;廣西莪朮:457.37 μg/mL、271.01 μg/mL;70% acetone萃取物清除DPPH自由基抗氧化能力最強,其EC50為蓬莪朮:0.66 mg/mL;廣西莪朮:3.14 mg/mL;50% ethanol萃取物對LPS誘導RAW 264.7巨噬細胞之抑制NO作用最強,其IC50為蓬莪朮:42.87 μg/mL;廣西莪朮:46.54 μg/mL),並可抑制PGE2和iNOS蛋白質表現,且蓬莪朮50% ethanol萃取物同時具有抑制COX-2蛋白表現作用;50% ethanol和水萃取物皆明顯具有延長部分凝血活?時間作用,且50% ethanol萃取物亦具有延長凝血?原時間作用。根據植化素分析結果顯示:抑制癌細胞生長作用與sesquiterpenes相關、抗氧化作用與polyphenols和flavonoids相關、抑制發炎作用與中極性植化素相關、抗凝血作用與中、高極性之植化素及多醣相關。據結果顯示單一指標成分無法反映莪朮之多功效,建議以植化素作為品質管制指標較能符合中藥臨床功效應用之品質規範,且使用水酒共煎最能體現莪朮之臨床功效。未來中藥品質管制建議應深化為”基原-植化素-劑型-藥效”的一致性,才有利於中藥臨床療效的穩定。
    Curcumae Rhizoma (CR) has been recorded in Traditional Chinese Medicine (TCM) that CR can be widely used to treat blood stasis syndrome, heartache, abdominal mass, dysmenorrhea, amenorrhea, traumatic injury, food stagnation, etc. Because the relationship between the clinical function of CR and modern pharmacology is still unclear, this study uses two origins of CRs, which are Curcuma phaeocaulis Val. (CP) and Curcuma kwangsiensis S. G. Lee et C. F. Liang (CK), to explore the relationship between their efficacy and phytochemicals. In this study, four different CR extracts were obtained. Therefore, anti-tumor test, anti-oxidation test, anti-inflammation test and anti-coagulation test were designed to explore their correlation: the results show that n-hexane extract has a relatively obvious cytotoxic effect on Hep G2 cell line and MG-63 cell line (CP IC50: 344.46 μg/mL, 282.41 μg/mL; CK IC50: 457.37 μg/mL, 271.01 μg/mL). 70% acetone extract has the best antioxidant effect in scavenging DPPH free radicals (CP EC50: 0.66 mg/mL. CK EC50: 3.14 mg/mL). 50% ethanol extract had the best inhibitory effect on NO production in LPS-induced RAW 264.7 cells (CP IC50: 42.87 μg/mL. CK IC50: 46.54 μg/mL) without significant cytotoxicity and can inhibit the expression of PGE2 and iNOS protein. Besides, 50% ethanol extract of CP also inhibits the expression of COX-2 protein. Both 50% ethanol and water extracts have the effect of prolonging the partial thromboplastin time, and 50% ethanol extract also has the effect of prolonging the prothrombin time. According to the results of phytochemical analysis, it shows that the inhibition of cancer cell growth is related to sesquiterpenes, the antioxidant effect is related to polyphenols and flavonoids, the anti-inflammatory effect is related to medium polar phytochemicals, and the anticoagulant effect is related to high to medium polar phytochemicals or polysaccharides. This study suggests that using phytochemicals as quality control indicators is more in line with the clinical efficacy of TCM, and at the same time, the clinical efficacy of CR is best reflected by using water and alcohol co-decoction. In the future, the quality control of TCM needs to deepen the consistency of "origin - phytochemicals - dosage form - efficacy", which is conducive to the stability of the clinical efficacy of TCM.
    描述: 碩士
    指導教授:王靜瓊
    委員:林宜信
    委員:侯文琪
    委員:王靜瓊
    資料類型: thesis
    顯示於類別:[生藥學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML39檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋